Basic and Clinical Andrology is now indexed in ESCI, PubMed, PubMed Central, and DOAJ.
Seminal plasma is a complex fluid that serves as a medium to carry, protect, and nourish spermatozoa after ejaculation up to fertilization, and as a functional modulator of spermatozoa function. Men are directly implicated in about 50% of couple infertility; however, in most cases of male infertility, the major treatment is female-oriented through Medically Assisted Reproductive Technologies (MART).
This article collection further explores the most recent research documenting the advancements in constitution, composition and functions of seminal plasma, the use of its components in the etiological diagnosis of male infertility, as well as its impacts on embryo’s implantation and ensuing pregnancy.
Submission is open to everyone.
Male hormonal contraception has been an active area of research for almost 50 years. However, at present, there is still a gap in contraceptive options for couples, and more particularly, effective reversible contraceptives for men.
This article collection further explores the most recent research documenting the advancements in male contraception.
Submission is open to everyone.
Featured blog: Vasalgel™ as a promising new male contraceptive – you asked, we answered
Basic and Clinical Andrology is a continuation of the French journal Andrologie, formerly published in the French language by Springer France. All content from Andrologie is freely available at Springer Link.
Although recent progress in cancer treatment has increased patient survival and improved quality of life, reproductive side effects are still for concern. One way to decrease gonadal impairment is to use cytoprotectors. In testicular cancer, N-acetylcysteine (NAC) has the ability to counteract etoposide-induced toxicity rather than preventing the etoposide cytotoxic effects over sperm DNA, suggesting that the administration of NAC to cells formerly exposed to etoposide is preferable to its prophylactic use. This reinforces the idea that there might be a new NAC mechanism over DNA.
Aims and scope
Basic and Clinical Andrology is an open access journal within the domain of andrology, covering all aspects of male reproductive and sexual health in humans and animal models. The journal aims to bring to light the various clinical advancements and research developments in andrology from the international community.
Basic and Clinical Andrology is a continuation of the French journal Andrologie and is the official journal of the French Society of Andrology (SALF). As an open-access journal, Basic and Clinical Andrology can ensure wide distribution and increased visibility of authors’ work.
Roger Mieusset, Editor-in-Chief
"Andrology is important enough in human life for knowledge not to be restricted to a small community. Open access makes an article available freely available to anyone soon after it is accepted for publication. Accessibility to knowledge in andrology is not only required for all those involved in their everyday occupational life with male problems, but also for any scientific or medical teams. In this way, open access - and Basic and Clinical Andrology - is an open door in the andrological world."
Basic and Clinical Andrology is the official journal of French Society of Andrology (SALF). Authors from SALF are entitled to a discounted article-processing charge of 1000 GBP which is payable upon editorial acceptance of their manuscript for publication. To facilitate this, SALF members should indicate their membership (in payment option number 3) when submitting a manuscript.
Basic and Clinical Andrology is affiliated with the French federation Centre d'Etude et de Conservation de Oeufs et du Sperme Humains (CECOS). Members of CECOS are entitled to a £250 discount on their article-processing charge which is payable upon editorial acceptance of their manuscript for publication. To facilitate this, eligible authors should indicate their membership (in payment option number 3) when submitting a manuscript.
Basic and Clinical Andrology is the official journal of the French Society of Andrology (SALF).
Annual Journal Metrics
35 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
83 days from submission to acceptance
28 days from acceptance to publication
39 Altmetric Mentions